1 0

    FDA Drug Approval, A075795, GLIPIZIDE

    FDA Drug Approval, A075795, GLIPIZIDE

    $89.00 USD
    $89.00 USD
    Sale Sold out

    Contents: Summary Basis for Approval

    ANDA: 075795
    Company: APOTEX
    Drug Name: GLIPIZIDE
    Active Ingredients: GLIPIZIDE
    Strength: 10MG
    Dosage Form/Route: TABLET;ORAL
    Action Date: 06/13/2001
    Marketing Status: Prescription
    Submission Classification: ORIG-1 TE Code: AB
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details